<DOC>
	<DOCNO>NCT01023230</DOCNO>
	<brief_summary>The purpose study determine DV-601 , investigational , therapeutic vaccine well-tolerated induce hepatitis B virus ( HBV ) -specific virological immunological response chronic hepatitis B ( CHB ) patient .</brief_summary>
	<brief_title>A Study Assess DV-601 Subjects With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Male female subject 18 65 year age . Signed informed consent . Diagnosis CHB candidate therapy Normal renal function Women childbearing potential must serum negative pregnancy test screening . Women childbearing potential male whose sexual partner childbearing potential must agree use dual method contraception . Liver disease CHB Documented coinfection hepatitis A virus ( HAV ) , hepatitis C virus ( HCV ) , HIV Previous therapy interferon alpha . Any antiviral therapy chronic hepatitis B within previous 3 month prior Screening Visit . Immunosuppressive treatment ( e.g . chemotherapy , highdose steroid ) within 6 month Screening Visit . Evidence cirrhosis ChildTurcottePugh ( CTP ) score â‰¥ 7 , either currently occasion past Clinically significant acute chronic illness , autoimmune disease , collagen vascular disease , immune deficiency , active uncontrolled infection , etc . determine investigator document medical history . Malignancy curatively treat , superficial skin cancer carcinoma situ cervix . Participation experimental protocol therapy within 28 day prior Screening Visit . Current substance alcohol abuse opinion investigator would interfere compliance interpretation study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>DV-601</keyword>
	<keyword>hepatitis B</keyword>
	<keyword>entecavir</keyword>
	<keyword>therapeutic vaccine</keyword>
</DOC>